Broadfin Capital’s Tetraphase Pharmaceuticals TTPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TTPH
BBA
Broadfin Capital's TTPH Position: Q2 2018 in Review
Broadfin Capital sold out of Tetraphase Pharmaceuticals (TTPH) in Q2 2018, closing a stake of 52,432 shares — an estimated $3.22M sold.
Broadfin Capital first reported a position in TTPH in Q2 2013 and held it in 10 quarters. The position peaked at $29.7M in Q4 2013. 90 funds tracked by Wall St. Rank hold TTPH as of Q2 2018.
- Broadfin Capital reported no remaining Tetraphase Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
- Broadfin Capital sold 52,432 Tetraphase Pharmaceuticals shares in Q2 2018, an estimated $3.22M.
- Broadfin Capital first reported a position in Tetraphase Pharmaceuticals in Q2 2013 and held it in 10 quarters.
- Broadfin Capital's Tetraphase Pharmaceuticals position peaked at $29.7M in Q4 2013.
- 90 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals as of Q2 2018.
Based on Broadfin Capital's 13F filing for Q2 2018, filed 14 Aug 2018.